Oscar Health, Inc. (NYSE:OSCR - Get Free Report) dropped 5.1% on Thursday . The company traded as low as $14.30 and last traded at $14.57. Approximately 12,827,392 shares were traded during trading, an increase of 74% from the average daily volume of 7,363,892 shares. The stock had previously closed at $15.35.
Analyst Upgrades and Downgrades
OSCR has been the topic of a number of recent analyst reports. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Piper Sandler cut Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price target for the company. in a research note on Monday. Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. UBS Group reiterated a "sell" rating and set a $11.00 price target (down from $15.00) on shares of Oscar Health in a report on Tuesday. Finally, Barclays assumed coverage on shares of Oscar Health in a report on Wednesday, July 2nd. They set an "underweight" rating and a $17.00 price target for the company. Five equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Reduce" and a consensus price target of $12.92.
View Our Latest Report on OSCR
Oscar Health Trading Down 9.6%
The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. The firm has a 50-day moving average of $16.35 and a 200 day moving average of $14.90. The company has a market cap of $3.53 billion, a P/E ratio of 49.55 and a beta of 1.90.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm's revenue for the quarter was up 42.2% compared to the same quarter last year. During the same period last year, the business posted $0.62 EPS. On average, analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 24.39% of the company's stock.
Hedge Funds Weigh In On Oscar Health
Large investors have recently added to or reduced their stakes in the business. Hsbc Holdings PLC lifted its position in shares of Oscar Health by 2.7% during the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock worth $313,000 after buying an additional 632 shares in the last quarter. Tempus Wealth Planning LLC grew its position in shares of Oscar Health by 6.7% during the 1st quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after purchasing an additional 906 shares in the last quarter. Focus Partners Wealth grew its position in shares of Oscar Health by 1.8% during the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock valued at $723,000 after purchasing an additional 949 shares in the last quarter. Xponance Inc. grew its position in shares of Oscar Health by 7.1% during the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after purchasing an additional 1,029 shares in the last quarter. Finally, CWM LLC grew its position in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares in the last quarter. Institutional investors own 75.70% of the company's stock.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.